FDA’s Shuren: ‘The Canary in the Coal Mine Is Actually Singing These Days’

The FDA has made important strides in improving its medical device review process, devices chief Jeffrey Shuren said this week. Since beginning an audit of the agency’s med-tech review procedures nearly two years ago, fewer medical device market applications have been sent back to companies and average decision times are on the decline, Shuren said.
Mass Device